ADVERTISEMENT
Jubilant Pharmova - Strong CDMO, Radiopharma Businesses; Undemanding Valuation: Nirmal Bang
Radiopharma business is back to pre-Covid level and is expected to grow in double digits with new launches, ramp-up in Ruby-fill.
29 Dec 2022, 10:43 AM IST 
Generics manufactured by Jubilant Pharmova (Source: Company website).
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Still Not convinced ? Know More
